Cite
HARVARD Citation
Musto, P. et al. (2017). Iron‐chelating therapy with deferasirox in transfusion‐dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study. British journal of haematology. pp. 741-750. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Musto, P. et al. (2017). Iron‐chelating therapy with deferasirox in transfusion‐dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study. British journal of haematology. pp. 741-750. [Online].